High rates of survival, immune reconstitution, and virologic suppression on second-line antiretroviral therapy in South Africa.

Abstract

To determine rates of survival, viral suppression, and immunologic change after 1 year on second-line antiretroviral therapy, we conducted a cohort study among 328 patients initiated on zidovudine, didanosine, and lopinavir/ritonavir. All patients who switched to standard second-line therapy at a large urban public-sector clinic in Johannesburg, South… (More)
DOI: 10.1097/QAI.0b013e3181bcdac1

Topics

4 Figures and Tables

Slides referencing similar topics